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INTRODUCTION 
 
Helicobacter pylori colonizes the human stomach and is responsible for chronic gastritis, peptic ulcer disease and gastric mucosa-associated lymphoma curable after eradication 
of microorganism by therapy. The treatment with two antimicrobial agent clarithromycin and amoxicillin (or metronidazole) and an acid suppressor, such as a proton pump 
inhibitor, is recommended by various groups [1], but resistance to these antibiotics is a major predictive factor for therapeutic failure. 
Investigation on the susceptibility of H. pylori to antibiotics is one of the main factors associated with successful eradication therapy. Growing resistance is related to the patterns 
of antibiotic consumption, and may vary within patient groups according to the geographic region. The geographic area and H. pylori primary resistance are clinically important, 
and should be considered in the choice of eradication regimens.  
The evolution of infection versus more severe gastric pathology has been related to virulence bacterial factors, the most frequently associated to microbial pathogenicity are two 
protein VacA and CagA, encodes by their genes [2, 3]. 
vacA is a polymorphic gene encoding a vacuolating cytotoxin, it is present in all strains and comprises two well characterized variable parts, the s region, which may exists as an 
s1 or s2 allele, and m region which may occurs as m1 or m2 allele. Another polymorphic site has been identified in this site, the i region, also in this case present as i1 or i2 allele.  
cagA (cytotoxin associated gene A) encodes an high molecular weight protein associated to the presence of a PAI [4].  CagA contains the five-aminoacid- motives EPIYA which are 
classified as  A, B, C or D depending on aminoacidic sequence flanking them. Usually the C region could be repeated more than once, while the D region circulates only in Asian 
countries. The EPIY-C acts as primary CagA phosphorilation site whereas epidemiological studies have indicated a correlation between disease severity and increased number of 
EPIYA-C motives [5].  
AIM 
 
In North Italy and many European countries H. pylory antibiotic susceptibility has 
been evaluated. As for Sicily, to our knowledge, no data are available for this aspect 
aim of this study was to evaluate antibiotic resistance pattern of one hundred strains 
isolated in three sicilian hospitals. Moreover, virulence–associated gene 
polimorphism of the same strains was carried out only for those isolated after our 
previous investigation [3]. 
METHODS 
 
Clinical H. pylori strains were isolated from a sample of 100 patients who underwent 
upper gastrointestinal endoscopy at the Endoscopy Services of the Ospedali Civili 
Riuniti in Sciacca (Agrigento), of the Gastroenterology, Internal Medicine and Elderly 
Care, and Emergency Surgery Units of the University Hospital A.O.U.P. Paolo 
Giaccone in Palermo, and Gastroenterology Division, M. Raimondi Hospital,  San 
Cataldo (CL).  
The biopsies positive to rapid urease testing were placed on Columbia agar (Oxoid, 
Basingstoke, Hampshire, UK) with the addition of 7% horse blood and 0.4% Dent 
supplement (Oxoid). The plates were incubated at 37°C under microaerobic 
conditions (CampyGen; Oxoid) for 3–6 days. 
H. pylori bacteria were identified on the basis of morphological and biochemical 
characteristics. 
For in vitro susceptibility testing of the H. pylori strains, a suspension equal to 
McFarland turbidity standard of 4 was prepared. Mueller Hinton agar (Oxoid), with 5% 
of sheep-blood, was used as culture medium to determinine antibiotic susceptibility 
and were inoculated by confluent swabbing of the surface with bacterial suspension. 
For each strain sensitivity to different antibiotics was assessed, zones of inhibition 
were read after 3 days and confirmed after 5 days. 
For virulence genotyping, DNA of each strain was used for amplify following genes: 
vacA, cagA   and 23S rRNA,using the specific primers [2,6,7]. 
RESULTS 
 
Antibiotic resistance assays, carried out by agar diffusion test, showed that the 
isolated strains were mainly resistant to the three most commonly used antibiotic. 
Results are represented in fig. 1. Clarithromycin resistance was confirmed by 
sequencing of the 23S rRNA which is the target for the antibiotic. 
The 15% of the analysed strains were resistant to more than one antibiotic. 
Interestingly and worryingly two strains were resistant to four antibiotics (amoxycillin, 
tetracycline, metronidazole, cephalotin) for one strain and amoxycillin, clarithromycin, 
metronidazole, cephalotin for the second one. No H. pylori strains was resistant to 
gentamicin and chloramphenicol. 
Molecular analysis, carried out by 23S rRNA sequencing revealed, for all resistant 
strains, a point mutation either in position A2142G or A2143G. Probably In two patients 
there was co-infection with a resistant and a sensitive strain, also correlated to the 
presence of two peaks in position 2142. 
For all the isolated strains molecular analysis has been carried out to test genes 
known to be virulence- related. In particular, vacA and cagA were analysed. Results are 
shown in tab. 1. 
Moreover, the EPIYA region was analysed revealing an high percentage of strains with 
ABC motif (fig. 2) well related with the higher amount of patients showing an inactive 
chronic gastritis and the absence of patients affected by gastric cancer. 
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CONCLUSIONS AND PERSPECTIVES 
 
H. pylori still represents a great challenge for clinicians as therapy success is rapidly 
decreasing. This phenomenon is related to resistance acquiring particularly to 
clarithromycin and metronidazole. Our results demonstrate a high percentage of 
bacterial strain resistant to clarithromycin, amoxicillin, and metronidazole, first line 
drugs used in eradicating therapy. Resistance percentage found in Sicily are higher 
than those reported for other Italian regions [8], but lower when compared to those 
found in other countries such as France [9] and Spain [10].   
According to Maastricht III [1] an epidemiological surveillance is always recommended 
in order to choose the suitable antibiotic therapy. Moreover antibiotic-susceptibility 
testing should be carried out, when possible, for every patient before starting 
eradicating therapy.  
DNA typing of virulence genes revealed the same genotype distribution found in other 
Italian regions and France [3] but a correlation between genotype and pathology 
severity or antibiotic resistance seems not to be possible at the moment.  
The relationship between  the number of EPIYA-C repeats and severity of the H.pylori-
associated pathology is confirmed by our results, and the EPIYA analysis seems to be 
a promising prognostic tool in the course of H.pylori infection. 
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        CGA+PU, n=17 CGA, n=29 CG, n=54   
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Tab 1 Virulence-associated H. pylori genotypes in patients with different 
gastrointestinal diseases. All patients  were affected by chronic gastritis 
inactive (CG), active (CGA), and active and associated with a gastric or 
duodenal peptic ulcer (CGA+PU). 
Fig. 1 Percentage of resistant H. pylori isolated strains  
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Fig. 2 Percentage of EPIYA motives in cagA-positive strains.   
